259 related articles for article (PubMed ID: 27117087)
1. Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
Aytan N; Choi JK; Carreras I; Brinkmann V; Kowall NW; Jenkins BG; Dedeoglu A
Sci Rep; 2016 Apr; 6():24939. PubMed ID: 27117087
[TBL] [Abstract][Full Text] [Related]
2. Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease.
Carreras I; Aytan N; Choi JK; Tognoni CM; Kowall NW; Jenkins BG; Dedeoglu A
Sci Rep; 2019 Jul; 9(1):10972. PubMed ID: 31358793
[TBL] [Abstract][Full Text] [Related]
3. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
5. Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer's Disease.
Bascuñana P; Brackhan M; Möhle L; Wu J; Brüning T; Eiriz I; Jansone B; Pahnke J
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830699
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.
Fagan SG; Bechet S; Dev KK
Mol Neurobiol; 2022 Mar; 59(3):1882-1895. PubMed ID: 35031916
[TBL] [Abstract][Full Text] [Related]
7. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
Bascuñana P; Möhle L; Brackhan M; Pahnke J
Drugs R D; 2020 Sep; 20(3):197-207. PubMed ID: 32696271
[TBL] [Abstract][Full Text] [Related]
9. Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?
Leßmann V; Kartalou GI; Endres T; Pawlitzki M; Gottmann K
J Neural Transm (Vienna); 2023 Aug; 130(8):1003-1012. PubMed ID: 37014414
[TBL] [Abstract][Full Text] [Related]
10. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
[TBL] [Abstract][Full Text] [Related]
11. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
13. Central effects of fingolimod.
Cruz VT; Fonseca J
Rev Neurol; 2014 Aug; 59(3):121-8. PubMed ID: 25030072
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod Suppresses a Cascade of Core Vicious Cycle in Dry Eye NOD Mouse Model: Involvement of Sphingosine-1-Phosphate Receptors in Infiltrating Leukocytes.
Xiao W; Fu S; Xu K; Feng R; Sun F; Ye W
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6123-6132. PubMed ID: 29214311
[TBL] [Abstract][Full Text] [Related]
15. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
18. Targeting microglia for the treatment of Alzheimer's disease.
McGeer PL; McGeer EG
Expert Opin Ther Targets; 2015 Apr; 19(4):497-506. PubMed ID: 25435348
[TBL] [Abstract][Full Text] [Related]
19. Esculentoside A suppresses Aβ(1-42)-induced neuroinflammation by down-regulating MAPKs pathways in vivo.
Yang H; Wang S; Yu L; Zhu X; Xu Y
Neurol Res; 2015 Oct; 37(10):859-66. PubMed ID: 26104317
[TBL] [Abstract][Full Text] [Related]
20. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
Pimentel LS; Allard S; Do Carmo S; Weinreb O; Danik M; Hanzel CE; Youdim MB; Cuello AC
J Alzheimers Dis; 2015; 47(2):373-83. PubMed ID: 26401560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
